Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06088225
Other study ID # Beijing Airdoc MPC Co., Ltd.
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 31, 2026

Study information

Verified date October 2023
Source Beijing Airdoc Technology Co., Ltd.
Contact QIU JENNY, MD
Phone +8618510386815
Email kkaiqiu@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.


Description:

This study is for testing the efficacy and safety of distance-image screens intended usage for preventing myopia in children with reading after a 6-meter-distant-image device. It was a prospective study. The investigators would like to recruit 100 volunteers, aged 6 years 16 in Beijing. All the volunteers will be complete examined their ocular parameters before using the distant-image screen in a random order for at least 2 hours daily for 12 month. The changes of ocular axial length and refractive error were both calculated before and after 12-month usage for paired t-test.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2026
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 12 Years
Eligibility Inclusion Criteria: - (1) Must be 6~12 years old; - (2) Must be best corrected visual acuity < logMAR: 0.1; - (3) Spherical Equivalence (SE) must be -1.00~ + 6.00 Diopter (D), - (4) Spherical Equivalence (SE) must have changed > 1.25 Diopter (D) in the recent 2 years; - (5) Must be astigmatism <1.75 Diopter (D); - (6) Must be anisometropia <1.75 Diopter(D). Exclusion Criteria: - (1) Strabismus disease; - (2) Amblyopia disease; - (3) Cataract disease; - (4) Glaucoma disease; - (5) Severe dry eye disease; - (6) Cannot use distance-image screen for 12 month; - (7) Other severe diseases that would effect the use of distance-image screen.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
distance-image screen
Distance-image screen is a screen make each image at distance of 6-meters to reduce the accommodation and convergence for eyes during the reading and learning with screens.

Locations

Country Name City State
China Airdoc MPC Opthalmology Clinics Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Airdoc Technology Co., Ltd.

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of ocular axial length (mm) IntraOcularLens (IOL) master biometry will exam each eye before the testing and after the testing with distance-image screen 12-month
Primary Changes of refractive error (D) Cycloplegic refraction with autorefractor will test each eye before the testing and after the testing with distance-image screen 12-month
Secondary Changes of center macular thickness (um) Optic Coherent Topograph (OCT) of macular fovea central thickness will be made to compare the thickness before and after using distance-image screen 12-month
Secondary Changes of subretina choroidal thickness (um) Optic Coherent Topograph (OCT) with Enhanced Depth Imaging (EDI) scan of macular fovea central thickness will be done to compare the thickness before and after using distance-image screen at 12-month
Secondary Changes of other regions choroidal thickness (um) Optic Coherent Topograph (OCT) with Enhanced Depth Imaging (EDI) scan of other regions choroidal thickness will be done to compare the thickness before and after using distance-image screen 12-month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05919654 - Clinical Evaluation of MyoCare in Europe (CEME) N/A
Recruiting NCT03402100 - Eye Drops Study for Myopia Control in Schoolchildren N/A
Recruiting NCT03865160 - Low-dose Atropine for Myopia Control in Children Phase 2/Phase 3
Not yet recruiting NCT06085430 - Kubota Glass Parameter Refinement Study N/A
Not yet recruiting NCT06405711 - To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia N/A
Recruiting NCT05881655 - Slow Myopia Progression With Different Irradiance Light N/A
Recruiting NCT05761379 - Clinical Study of Light Therapy to Control Myopia Progression in Children N/A
Not yet recruiting NCT05760911 - Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches N/A
Recruiting NCT04722874 - Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control N/A
Not yet recruiting NCT06221592 - Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses N/A
Completed NCT04806763 - Myopia Control With Orthokeratology Contact Lenses in Spain N/A
Completed NCT04806711 - Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children N/A
Completed NCT04806698 - Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia N/A
Recruiting NCT05894382 - Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control N/A
Completed NCT05683535 - Adverse Events Related to Low Dose Atropine
Completed NCT05300321 - DIMS-myopia Progression ADN Axial Length Growth N/A
Withdrawn NCT03519490 - Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children? N/A
Completed NCT05372991 - Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop Phase 1/Phase 2
Active, not recruiting NCT05373693 - Myopia-control Efficacy by Peripheral Defocus Lens (PDL) N/A
Completed NCT05007626 - Near Horizontal Heterophoria in Chinese Children